Chamomile (Matricaria chamomilla).
Grandma's sleep tea. Actually has some science. Mild anxiolytic and sleep support through apigenin binding to GABA-A receptors.
Reviewed March 2026
What Chamomile (Matricaria chamomilla) is, and what it does.
- Does it work
- Well researched for mild anxiety and sleep. Well tolerated, effective for gentle relaxation.
- How much to take
- Start around 220mg to 1,100mg of extract a day, the daily maintenance band. A strong cup or two of the flower tea is the everyday version of the same thing.
- Time to feel it
- About two weeks of daily use, with the difference gone two weeks after stopping.
- The first dose
- 30-60 minutes for relaxation. Sleep benefits same night.
- With regular use
- Weeks of daily use tend to show up as steadier evening wind-down and better rated sleep quality in trials, rather than as sedation you can feel.
- How well tolerated
- Well tolerated. Ragweed allergy cross-reactivity possible. Avoid before surgery.
- How it feels
- Gentle calm. Takes the edge off without drowsiness. Familiar, comforting.
- The overlooked benefit
- The blue oil is not in the flower. Its colour is chamazulene, created from a colourless precursor by the heat of steam distillation.
220 to 1,100mg a day is where Chamomile (Matricaria chamomilla) works.
Source: Mao et al. 2016 Phytomedicine RCT; Amsterdam et al. 2009 J Clin Psychopharmacol
A randomised controlled trial assigned 80 Taiwanese postnatal women with poor sleep quality to drink chamomile tea daily for two weeks or to receive usual postpartum care. At the end of the two weeks the tea group scored lower on physical-symptoms-related sleep inefficiency and on the Edinburgh Postnatal Depression Scale. At the 4-week assessment, two weeks after the tea stopped, scores on all three instruments were similar in the two groups again. A separate pilot trial of 270 mg of standardised chamomile extract twice daily for 28 days in 34 adults with chronic primary insomnia found no significant difference from placebo on sleep diary measures.
Kept, not banked. The cited trial measured a return toward baseline after the last dose, so the effect holds while it is taken daily, not stored up. That rests on the trial window above.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 20 human trials with 60% consistency.
- sleep qualityMeta-analysis
- calm and everyday stressRandomised trial
- digestive comfortNarrative review
- apigenin binding at the benzodiazepine site of the GABA-A receptorIn vitro study
- a healthy inflammatory responseIn vitro study
Questions people ask about Chamomile (Matricaria chamomilla).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Chamomile is one of the richest dietary sources of apigenin, and it is apigenin that binds the benzodiazepine site on the GABA-A receptor to produce chamomile's calming action on the nervous system. Taking the two together concentrates that same receptor-level mechanism behind relaxation.
Both nudge the same GABA-A receptor from different points: chamomile's apigenin sits at the benzodiazepine site while valerian's valerenic acid modulates the receptor's beta 2 and beta 3 subunits, so the two support inhibitory GABA tone through separate handholds. They have long been combined in evening and wind down blends, where the calming effect adds together.
Passionflower raises GABAergic tone through its own flavonoids, the same inhibitory pathway that chamomile's apigenin works on, which is why the two are classic partners in calming and evening teas. Stacked, their relaxing effect is additive rather than each acting alone.
L-theanine raises alpha wave activity and softens excitatory glutamate signaling, while chamomile's apigenin supports the opposite inhibitory GABA side of the same balance, so the pair approaches a relaxed but alert state from two directions. It is a common combination in daytime calm formulas.
Lemon balm rosmarinic acid inhibits GABA transaminase, so existing GABA is broken down more slowly. Chamomile apigenin binds the benzodiazepine site of the GABA-A receptor instead, giving two handles on the same inhibitory tone.
Honokiol and magnolol act as positive modulators at the GABA-A receptor at a site distinct from the benzodiazepine site apigenin occupies. Modulators at separate sites on one receptor add rather than compete.
Chamomile flowers carry luteolin glycosides alongside apigenin, so an extract already contains both. Luteolin has its own reported GABA-A and mast cell activity, which is part of why whole extract and isolated apigenin behave differently.
Melatonin signals through MT1 and MT2 receptors to shift sleep timing, while chamomile acts on GABA-A to lower excitatory tone. Timing and tone are separate levers on the same night.
Magnesium blocks the NMDA receptor channel and is a cofactor for the enzyme that makes GABA, while the glycine carrier itself acts on inhibitory glycine receptors. Both sit on the inhibitory side that chamomile's GABA-A modulation also occupies.
Glycine is an inhibitory transmitter at its own receptor and also lowers core body temperature through peripheral vasodilation, which is part of normal sleep onset. Neither mechanism overlaps with GABA-A modulation.
Tryptophan is the precursor for serotonin and then melatonin, a route entirely separate from GABA-A binding. It supplies the material for the timing signal while chamomile lowers excitatory tone.
5-HTP is one enzymatic step from serotonin and feeds the same downstream melatonin route. That pathway does not compete with apigenin at the GABA-A receptor.
Kavalactones modulate GABA-A channels and sodium channel activity, which stacks directly on chamomile's GABA-A action. Effects on calm add, so combined intake should be approached with that in mind.
Withanolides are associated with lower cortisol output and are reported to have GABA-mimetic activity as well. The hormonal axis is a slower lever than chamomile's direct receptor modulation.
Tart cherry carries small amounts of melatonin along with anthocyanins, so it nudges sleep timing rather than receptor tone. That is a different mechanism from GABA-A modulation.
Caffeine blocks adenosine receptors and raises cortical arousal, working directly against the lowered excitatory tone chamomile produces. Taken close together the two cancel out.
Menthol relaxes intestinal smooth muscle through calcium channel effects, and chamomile's flavonoid and volatile fractions are described as antispasmodic in monograph literature. The two appear together in classical carminative teas. The combination has been studied more as a multi-herb product than as an isolated pair.
Ginger acts on gastric emptying and on serotonin signalling in the gut wall, while chamomile is used for its antispasmodic volatile oil and apigenin content. Herbal monographs describe both under normal digestive comfort. Grounding is traditional use plus separate single-herb work, not a combination trial.
Marshmallow root contributes a polysaccharide mucilage that coats mucosal surfaces, which is a physical effect, while chamomile contributes flavonoids and volatile oil. The roles are different enough that they do not overlap. This is formulation convention with a long monograph history behind it.
Slippery elm bark forms a viscous gel on contact with water and is used as a demulcent alongside chamomile in gut-comfort blends. The mechanisms sit side by side rather than combining. Evidence for either herb in this role is largely traditional and observational.
Licorice contributes glycyrrhizin and flavonoids used for mucosal comfort, chamomile contributes apigenin and bisabolol. Deglycyrrhizinated grades are chosen where the mineralocorticoid effect of glycyrrhizin on potassium and blood pressure is a concern. Anyone stacking the two should know licorice carries that watch point and chamomile does not.
Chamomile's principal flavone is apigenin, which sits in the same structural family as quercetin and is handled by the same glucuronidation and sulfation enzymes. Taken together they compete for those conjugating enzymes, which can raise circulating levels of either. That is an established metabolic overlap rather than a demonstrated benefit.
Rutin and chamomile's apigenin-7-glucoside are both glycosides that need bacterial deglycosylation in the colon before the aglycone is absorbed. They draw on the same microbial enzyme capacity. The consequence of loading both at once has not been measured in people.
Apigenin binds the benzodiazepine site of the GABA-A receptor complex in binding studies, and supplemental GABA is taken for the same calm-state purpose. Their routes differ, since orally taken GABA crosses into the brain poorly. Additive drowsiness is the practical thing to watch for in any evening stack.
Lavender's linalool and chamomile's bisabolol and apigenin are both used for a calm evening state, and the two share space in most sleep teas. Whether their effects on subjective sleepiness add has not been measured for the pair. Combination data is limited, so this reads as convention supported by single-herb work.
Honey is the customary sweetener and demulcent vehicle for a chamomile infusion, and it coats the throat while the infusion is drunk. Its role is palatability and mucosal contact rather than any change to chamomile chemistry. This is traditional practice.
Talk to a doctor before taking Chamomile (Matricaria chamomilla) if any of these apply to you: ragweed allergy. These are flags to check first, not effects Chamomile (Matricaria chamomilla) is known to cause.
Not medical advice. Show the label to your pharmacist.What Chamomile (Matricaria chamomilla) actually does.
Chamomile's active side splits in two. There's the volatile oil, carrying alpha-bisabolol and the chamazulene that forms from matricin during distillation, and there's the water-soluble flavonoid fraction, mostly apigenin-7-O-glucoside.
You won't find chamazulene in a fresh flower at all. It only appears when the heat of steam distillation works on matricin, and that's why the oil comes out blue while the dried flower doesn't.
Apigenin-7-glucoside barely gets through your gut wall while its sugar is still attached. Gut bacteria have to snip that sugar off first, and the free aglycone is what crosses, so your microbiota has a say in how much you absorb.
A water infusion pulls mainly the flavonoid glycosides and only a sliver of the volatile oil. A hydroalcoholic extract or a distilled oil hands you a very different constituent profile from the same plant.
Where Chamomile (Matricaria chamomilla) comes from.
Chamomile flowers are picked in full bloom and dried gently so the aromatic oils stay put. What happens next decides what you get: hot water pulls out the flavonoids that make up a tea, alcohol pulls out both fractions for a capsule or tincture, and steam distillation gives the blue essential oil, which is a different thing again.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
German chamomile is field-grown and the flower heads are harvested at full bloom, when volatile oil content peaks; Egypt, Croatia, Hungary and Argentina are the usual growing regions.
Flowers are dried at controlled low temperature to hold the volatile oil and to bring water activity down for storage; over-drying strips the terpenes.
Which solvent is used decides the product: water gives the flavonoid glycosides, ethanol and water gives both fractions, steam distillation gives the blue oil and converts matricin to chamazulene, and supercritical CO2 gives the terpenes without that heat step.
Extracts are filtered clear of plant solids and concentrated under vacuum; distilled oil is separated from the water phase.
Flavonoid extracts are assayed by HPLC to a declared apigenin-7-glucoside content; oils are specified on bisabolol and chamazulene, and botanical identity is confirmed against the monograph so that Roman chamomile is not substituted.
The material is cut for tea bags, spray-dried onto a carrier for capsules, or standardised into a tincture or glycerite.
Getting Chamomile (Matricaria chamomilla) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In a meta-analysis pooling five trials, chamomile lowered the Pittsburgh Sleep Quality Index by about 1.9 points versus control, with the clearest gains in fewer night-time awakenings.Meta-analysis. Kazemi et al., 2024 (Complementary Therapies in Medicine). PMID 39106912 ↗
- Over 8 weeks, oral chamomile extract produced a significantly greater fall in self-rated tension and anxiety scores than placebo (P = 0.047), pointing to a mild calming effect.Randomised trial. Amsterdam et al., 2009 (Journal of Clinical Psychopharmacology). PMID 19593179 ↗
- In 80 older women taking 400 mg chamomile daily for 12 weeks, vasomotor symptom scores such as hot flushes fell more than placebo (mean difference -0.82, 95% CI -1.25 to -0.39), with no measurable change in psychological, physical, sexual or overall quality-of-life scores.Randomised trial. Mohsenzadeh-Ledari et al., 2026 (Journal of Integrative and Complementary Medicine). PMID 41761999 ↗
- This Cochrane review of 27 studies on supplements for period pain found only very limited low-quality evidence, from a single trial in 160 women, that chamomile eased pain more than an anti-inflammatory comparator, and no high-quality evidence for any supplement.Meta-analysis. Pattanittum et al., 2016 (Cochrane Database of Systematic Reviews). PMID 27000311 ↗
- Analysis of chamomile plant material reports its nutritional composition and antioxidant capacity in laboratory assays, with sensory scores for the infusion.In vitro study. Kerbab et al., 2025 (Foods). PMID 40077541 ↗
- A homeopathic Matricaria chamomilla preparation given alongside vaccination altered antibody titres in cattle; titre is an immune marker, not a clinical outcome, and the preparation is not a standard extract.Animal study. de Souza Reis et al., 2008 (Journal of Veterinary Science). PMID 19043320 ↗
- Dietary chamomile and lemongrass essential oils changed growth and antioxidant markers in farmed fish.Animal study. Cheyadmi et al., 2025 (Fish Physiology and Biochemistry). PMID 41186791 ↗
- The authors review chamomile preparations in women with a hormonal and metabolic reproductive condition and describe the human evidence base as small and heterogeneous.Narrative review. Firoozi et al., 2026 (Food Science and Nutrition). PMID 41767834 ↗
- A review of cosmeceutical ingredients names chamomile extract among topical botanicals used for skin comfort and describes the supporting evidence as mostly preclinical.Narrative review. Chan et al., 2024 (Skin Research and Technology). PMID 39233460 ↗
- Practice recommendations for oral mucosal care name chamomile rinses among the topical soothing options described in the literature.Narrative review. Gazal et al., 2026 (World Journal of Experimental Medicine). PMID 41883451 ↗
These are the studies our verdict leans on, chosen from the 2,037 we read for Chamomile (Matricaria chamomilla). The full linked list is below.
Problems people have reported.
Read this carefully. These are 67 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Chamomile (Matricaria chamomilla) is, not how risky it is. A report is not proof Chamomile (Matricaria chamomilla) caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.


